Company Contents
Quick Facts & Snapshot
Summary
The global continuous glucose monitoring (CGM) market is entering a scale-up phase, with leading CGM market companies leveraging advanced sensors, connectivity, and analytics to improve safety and therapeutic efficiency. The market is projected to grow from US$ 13.70 Billion in 2025 to US$ 27.60 Billion by 2032, reflecting a robust 10.20% CAGR.
Source: Secondary Information and ReportMines Research Team - 2026
Ranking Methodology
The ranking of CGM market companies is based on a composite scoring model that balances quantitative and qualitative indicators. Core criteria include 2025 CGM revenue, multi-year revenue growth, installed sensor base, and share of connected users. We also assess technology differentiation, such as factory calibration, sensor wear duration, interoperability with insulin pumps, and AI-driven decision support. Portfolio breadth across professional, real-time, and intermittently scanned CGM, plus coverage of Type 1, Type 2, and gestational use cases, is weighted significantly. Service and distribution capabilities, geographic reach, payer access, and ability to secure long-term contracts with health systems and payers further influence ranking. Finally, we consider evidence generation, clinical trial depth, regulatory track record, and the robustness of digital ecosystems. Scores are normalized, peer-benchmarked, and reviewed to ensure that both current scale and future competitiveness are reflected.
Top 10 Companies in CGM
Source: Secondary Information and ReportMines Research Team - 2026
Detailed Company Profiles
Dexcom, Inc.
Dexcom is a global CGM leader focused on real-time glucose monitoring and connected diabetes care for insulin-intensive patients.
Abbott Laboratories (FreeStyle Libre)
Abbott’s Diabetes Care business is a scale player in sensor-based glucose monitoring with a focus on intermittent scanning CGM.
Medtronic plc
Medtronic is a diversified medtech major with CGM tightly integrated into its insulin pump and automated insulin delivery platforms.
Senseonics Holdings, Inc.
Senseonics develops implantable, long-term CGM sensors designed for patients seeking fewer insertions and extended wear duration.
Roche Diabetes Care
Roche Diabetes Care offers an integrated ecosystem combining CGM, SMBG, and digital apps for holistic diabetes management.
Ascensia Diabetes Care / PHC Group
Ascensia is a global diabetes care player commercializing CGM technologies, including implantable solutions, through established distribution networks.
Ypsomed Holding AG
Ypsomed specializes in insulin delivery systems that integrate with leading CGM technologies to enable automated insulin delivery solutions.
POCTech (Medtrum / related entities)
POCTech and affiliated entities provide cost-efficient CGM systems and patch pumps targeting high-volume, price-sensitive diabetes populations.
Nemaura Medical Inc.
Nemaura Medical is an emerging innovator developing non-invasive or minimally invasive CGM and metabolic monitoring wearables.
A. Menarini Diagnostics
A. Menarini Diagnostics is a regional diagnostics specialist offering CGM solutions and distribution services in European diabetes markets.
SWOT Leaders
Dexcom, Inc.
SWOT Snapshot
Market-leading accuracy, strong brand recognition, extensive clinical evidence, and deep integration with digital health ecosystems and insulin pumps.
Premium pricing in many markets, reliance on a concentrated product portfolio, and exposure to reimbursement decisions in key countries.
Expansion into Type 2 and prediabetes populations, broader primary care adoption, and further penetration in Asia Pacific and Latin America.
Pricing pressure from low-cost competitors, rapid innovation cycles, cybersecurity risks, and potential tighter reimbursement in mature markets.
Abbott Laboratories (FreeStyle Libre)
SWOT Snapshot
High-volume manufacturing, attractive price point, broad reimbursement coverage, and strong brand recognition among Type 2 diabetics globally.
Perceived as less feature-rich than full real-time CGM, limited integration in some pump ecosystems, and intense internal portfolio priorities.
Upselling users to advanced Libre versions, expansion into wellness and metabolic health, and scaling in emerging markets with payor partnerships.
Competition from both premium and budget CGM offerings, regulatory scrutiny on data privacy, and macroeconomic pressures on public healthcare budgets.
Medtronic plc
SWOT Snapshot
Large installed insulin pump base, strong hospital presence, and experience with automated insulin delivery and closed-loop systems.
Historically slower sensor innovation cycles, complex product ecosystem, and dependence on integrated pump-CGM offerings.
New approvals for closed-loop systems, geographic expansion in Asia Pacific, and cross-selling within existing cardiovascular and hospital customers.
Competitive pressure from standalone CGM leaders, regulatory delays, cybersecurity and interoperability challenges, and pricing pressures from payors.
CGM Market Regional Competitive Landscape
North America remains the largest revenue pool for CGM market companies, driven by high diabetes prevalence, broad commercial and public reimbursement, and rapid adoption of automated insulin delivery. Dexcom, Abbott, and Medtronic dominate, while emerging players such as Senseonics gain traction in specific, highly engaged patient niches.
In Europe, universal healthcare systems and strong endocrinology networks foster structured CGM adoption, particularly among Type 1 patients. CGM market companies like Dexcom, Abbott, Roche, and A. Menarini Diagnostics compete for tenders and regional contracts, with pricing, evidence of outcomes improvement, and integration into national registries critical for success.
Asia Pacific is the fastest-growing region, with China and India representing substantial underpenetrated populations. POCTech and other regional players compete on affordability, while Dexcom and Abbott expand through localized pricing, manufacturing partnerships, and targeted education. CGM market companies increasingly tailor solutions for diverse healthcare infrastructures and out-of-pocket payment models.
Latin America shows steady CGM uptake despite budget constraints, with Brazil and Mexico leading regional adoption. Abbott’s FreeStyle Libre and Roche leverage strong distribution, while Dexcom selectively targets private insurance and affluent self-pay segments. Successful CGM market companies build hybrid reimbursement models and collaborate closely with diabetes societies.
The Middle East and Africa region remains nascent but strategically important, with rising obesity and diabetes incidence. Wealthier Gulf states invest in advanced CGM and pump technologies from Dexcom, Abbott, and Medtronic, while other markets focus on cost-effective solutions. Education, physician training, and localized service networks are central competitive differentiators for CGM market companies.
CGM Market Emerging Challengers & Disruptive Start-Ups
Emerging Challengers & Disruptive Start-Ups
Developing a cloud-native analytics layer that overlays any CGM brand, delivering AI-driven insulin dosing suggestions and hypoglycemia risk alerts.
Working on enzyme-optimized sensor chemistries to extend CGM wear time beyond 21 days while improving accuracy in extreme glucose ranges.
Offering a low-cost, smartphone-first CGM platform focused on Type 2 diabetics and prediabetics in tier-2 and tier-3 cities.
Pursuing optical, patch-based non-invasive glucose monitoring targeting wellness, sports performance, and insurance-linked lifestyle programs.
Building a virtual clinic model combining multi-brand CGM devices with remote endocrinology services and payer-aligned outcomes guarantees.
CGM Market Future Outlook & Key Success Factors (2026-2032)
From 2025 to 2031, cumulative investments in metro expansions and station safety upgrades are projected to surpass significant amounts. The total market will scale from US$ 2.27 Billionin 2025 to US$ 3.38 Billion by 2031, reflecting a 6.90% CAGR. Winning CGM market companies will share several attributes. First, they will embed native IoT sensors, enabling predictive maintenance contracts that can double recurring revenue within five years. Second, modular design philosophies—interchangeable panels, plug-and-play controllers—will shorten installation windows and appeal to cost-sensitive public operators.
Localization strategies will also define competitive edges. Suppliers that establish regional assembly plants to meet content rules in India, Brazil, or the U.S. are likely to capture bonus points in tenders. Finally, sustainability credentials will move from optional to mandatory. Recyclable composite panels, energy-efficient brushless motors, and life-cycle carbon disclosures will become bid differentiators. In short, the coming decade rewards CGMmarket companies that marry digital intelligence with manufacturing agility and regulatory foresight.
Frequently Asked Questions
Find answers to common questions about this company report.